[Rhabdomyosarcoma in childhood. Report of 27 cases (author's transl)].
Twenty-seven cases of rhabdomyosarcoma in children between one month and 14 years of age are reported. The most frequent histologic type was the embryonal sarcoma and almost half of the cases were diagnosed in advanced clinical stages. Treatment consisted on the combination of surgery, radiotherapy and chemotherapy (vincristine, cyclophosphamide and actinomicin-D in non metastatic cases, plus adriamycin when metastases were present). The survival rate is 57.7% and the survival with no evidence of disease 53.8%, with observation periods from eight months to four years.
D000293:Adolescent; D000367:Age Factors; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008637:Mesenchymoma / Q000175:diagnosis* / Q000188:drug therapy; D012208:Rhabdomyosarcoma / Q000175:diagnosis* / Q000188:drug therapy; D014750:Vincristine / Q000627:therapeutic use
D003609:Dactinomycin; D014750:Vincristine; D003520:Cyclophosphamide
Rabdomiosarcoma en la edad infantil. A propósito de 27 casos.